LABU

Direxion Daily S&P Biotech Bull 3X ETF

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$79M476.2k shares
AddQ1 2026
$11M
$166.09
$186.00
Jim SimonsRenaissance Technologies
$-3.7M
ExitQ1 2026
$3.7M
--
$186.00
Ken GriffinCitadel Advisors
$68M426.8k shares
ExitQ4 2025
$71M
$159.39
$186.00
Ken GriffinCitadel Advisors
$68M426.8k shares
TrimQ4 2025
$3.2M
$159.39
$186.00
Jim SimonsRenaissance Technologies
$3.7M22.9k shares
ExitQ4 2025
$1.9M
$159.39
$186.00
Jim SimonsRenaissance Technologies
$3.7M22.9k shares
AddQ4 2025
$1.7M
$159.39
$186.00

News

247wallst.comLABU Could Rip Higher if Biotech Finally Gets Its Long-Awaited Breakout247wallst.comApr 27247wallst.comEqual-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now247wallst.comApr 23defenseworld.net34,270 Shares in Direxion Daily S&P Biotech Bull 3x Shares $LABU Purchased by JPMorgan Chase & Co.defenseworld.netApr 5